Prescription of Direct Oral Anticoagulants to Patients With Moderate-to-Advanced CKD: Too Little or Just Right?

Authors :: Bénédicte Stengel
Viviane Calice da Silva
Charlotte Tu
Solène M. Laville
Bruce M. Robinson
Brian Bieber
Danilo Fliser
Ziad A. Massy
Michelle M.Y. Wong
Roberto Pecoits-Filho
Sophie Liabeuf
CHU Amiens-Picardie
Mécanismes physiopathologiques et conséquences des calcifications vasculaires - UR UPJV 7517 (MP3CV)
Université de Picardie Jules Verne (UPJV)-CHU Amiens-Picardie
Centre de recherche en épidémiologie et santé des populations (CESP)
Université de Versailles Saint-Quentin-en-Yvelines (UVSQ)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Hôpital Paul Brousse-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris-Saclay
Arbor Research Collaborative for Health
Saarland University [Saarbrücken]
University of Michigan [Ann Arbor]
University of Michigan System
Pontifícia Universidade Católica do Paraná (PUCPR)
Hôpital Ambroise Paré [AP-HP]
Source :: Kidney International Reports, KIDNEY INTERNATIONAL REPORTS, KIDNEY INTERNATIONAL REPORTS, 2021, 6 (9), pp.2496--2500. ⟨10.1016/j.ekir.2021.06.004⟩
Publication Year :: 2021
Publisher :: Elsevier BV, 2021.
Abstract: International audience; No abstract available

Subjects :: vitamin K antagonist
medicine.medical_specialty
medicine.drug_class
business.industry
[SDV]Life Sciences [q-bio]
direct oral anticoagulant
Vitamin K antagonist
Nephrology
Internal medicine
Research Letter
CKD
medicine
oral anticoagulants
Medical prescription
business
ComputingMilieux_MISCELLANEOUS

Full Text Access

Tools